CEO Update: Outcomes of the 2013-14 Budget for NHMRC

ARCHIVED CONTENT – For reference purposes only

I am pleased to provide an update on the outcome of the 14 May Federal Budget as it relates to the National Health and Medical Research Council.

In 2013-14, NHMRC is receiving $1.3 million additional funding for two budget measures:

  • $0.7 million funding to conduct work to expedite clinical trials reform in Australia, in conjunction with the Department of Innovation, Industry, Climate Change, Science, Research, and Tertiary Education (DIICCSRTE), and agencies within the Health portfolio.
  • $0.6 million funding into research to develop an acute rheumatic fever vaccine, conjointly with the Health Research Council of New Zealand.

Funding for health and medical research, through the NHMRC’s Medical Research Endowment Account, has also increased from $689.3 million in 2012-13 to $771.2 million in 2013-14, and is forecast to increase to $859.9 million in 2014-15.

This reflects the changes made in October’s MYEFO, and NHMRC’s alignment of its grant payment practices with Commonwealth Grant Guidelines. From 2012-13, NHMRC grants are paid one month in arrears instead of three months in advance.

The change to the timing of grant payments has no impact on the current level of grant funding or existing funding commitments, nor does it impact upon individual research projects or researchers.

More information on the budget is available from

Professor Warwick Anderson AM
Chief Executive Officer
National Health and Medical Research Council